L960-0151 Screening compound: N-(1-benzylpiperidin-4-yl)-3-[(6-oxo-3-phenyl-1,6-dihydropyridazin-1-yl)methyl]-1,2,4-oxadiazole-5-carboxamide

L960-0151 Screening compound: N-(1-benzylpiperidin-4-yl)-3-[(6-oxo-3-phenyl-1,6-dihydropyridazin-1-yl)methyl]-1,2,4-oxadiazole-5-carboxamide
L960-0151 Screening compound: N-(1-benzylpiperidin-4-yl)-3-[(6-oxo-3-phenyl-1,6-dihydropyridazin-1-yl)methyl]-1,2,4-oxadiazole-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L960-0151
N-(1-benzylpiperidin-4-yl)-3-[(6-oxo-3-phenyl-1,6-dihydropyridazin-1-yl)methyl]-1,2,4-oxadiazole-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L960-0151

Molecular Formula

C26H26N6O3 (C26 H26 N6 O3)

Compound Name

N-(1-benzylpiperidin-4-yl)-3-[(6-oxo-3-phenyl-1,6-dihydropyridazin-1-yl)methyl]-1,2,4-oxadiazole-5-carboxamide

IUPAC name

N-(1-benzylpiperidin-4-yl)-3-[(6-oxo-3-phenyl-16-dihydropyridazin-1-yl)methyl]-124-oxadiazole-5-carboxamide

SMILES

O=C(c1nc(CN(C(C=C2)=O)N=C2c2ccccc2)no1)NC1CCN(Cc2ccccc2)CC1

InChI

InChI=1S/C26H26N6O3/c33-24-12-11-22(20-9-5-2-6-10-20)29-32(24)18-23-28-26(35-30-23)25(34)27-21-13-15-31(16-14-21)17-19-7-3-1-4-8-19/h1-12,21H,13-18H2,(H,27,34)

InChI Key

IMEVLCBQSFHUQD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15137764

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

470.53

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.677

Distribution Coefficient, logD

1.232

Water Solubility, LogSw

-2.98

Polar Surface Area

89.166

Acid Dissociation Constant (pKa)

14.57

Base Dissociation Constant (pKb)

8.83

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.90

L960-0151 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

C-Met Library (15277 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L960-0151 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L960-0151?
Check Price and Availability of L960-0151, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L960-0151 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L960-0151
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L960-0151
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L960-0151 available by request